Skip to main content
. 2009 Sep;158(2):610–620. doi: 10.1111/j.1476-5381.2009.00341.x

Figure 6.

Figure 6

Scheme of possible mechanisms underlying the antagonism between cetuximab and oxaliplatin, involving modulation of redox status. CTX, cetuximab; EGF, epidermal growth factor; GSH, glutathione; PI3K, phosphatidylinositol-3 kinase; PIP2, phosphatidylinositol bisphosphate; PIP3, phosphatidylinositol trisphosphate; PTEN, phosphatase and TENsin homologue, ROS, reactive oxygen species; shRNA, short hairpin RNA.